Welcome to the G-FINDER survey

The G-FINDER survey tracks annual investment into R&D for new products and technologies to address priority global health challenges. This includes basic research and the development of new drugs, vaccines, diagnostics and other tools for global health priorities that disproportionately affect people in low- and middle-income countries, including neglected diseases (NDs)emerging infectious diseases (EIDs) and sexual and reproductive health (SRH) issues.

As part of the ongoing evolution and improvement of the G-FINDER project, we have made the following changes to the survey scope:

NEW: Data Tags. We have added a ‘Tag’ feature, so you can provide more details about your projects by adding one or more tags, for example “paediatric formulation”, “ODA funding” and “antimicrobial resistance”. You can either choose from our pre-defined options in the dropdown, or add your own customised tags.

If the funding is linked to a clinical trial number or product name, it is helpful to add those as tags too. Just create your own free-text tag like: “Clinical trial number: NCT123456” or “Product name: paracetamol”. Using this format, including the colon, helps us process your data.

Although adding them is optional, we encourage you to add any relevant tags to your projects, so that we can better understand how your work fits into the global health landscape. You can add as many tags as you want to each project.

The survey is conducted by Policy Cures Research and funded by the Bill & Melinda Gates Foundation. For more information, please refer to the frequently asked questions.


Before you start the survey

G-FINDER reports and data portal

Our unique database of R&D investment data for global health issues can be freely accessed through the G-FINDER data portal.

Our analysis and reports based on this data can be found here.

Key dates

14 June 2024
Deadline for completing the survey


55 days left to complete the survey.